Alder Research Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 20.00 K
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 79.42%
- Profit Growth 4087.93%
- Ebitda 2585.96%
- Net Worth 134.45%
- Total Assets 30.13%
About Alder Research Chemicals
Alder Research Chemicals Private Limited (ARCPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 16 July 2020 (Four years and six months 30 days old ). Its registered office is in Khammam, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 20.00 K , as per Ministry of Corporate Affairs (MCA) records.
Naidu Shivaji and Venkateswararao Naidu serve as directors at the Company.
Company Details
-
Location
Khammam, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24110TG2020PTC141782
-
Company No.
141782
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Jul 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Alder Research Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naidu Shivaji
|
Director | 16-Jul-2020 | Current |
|
Venkateswararao Naidu
|
Director | 16-Jul-2020 | Current |
Financial Performance of Alder Research Chemicals.
Alder Research Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 79.42% increase. The company also saw a substantial improvement in profitability, with a 4087.93% increase in profit. The company's net worth Soared by an impressive increase of 134.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alder Research Chemicals?
Unlock access to Alder Research Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alder Research Chemicals?
Alder Research Chemicals has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alder Research Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alder Research Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.